Literature DB >> 10441299

Pathobiology of ischaemic stroke: an integrated view.

U Dirnagl1, C Iadecola, M A Moskowitz.   

Abstract

Brain injury following transient or permanent focal cerebral ischaemia (stroke) develops from a complex series of pathophysiological events that evolve in time and space. In this article, the relevance of excitotoxicity, peri-infarct depolarizations, inflammation and apoptosis to delayed mechanisms of damage within the peri-infarct zone or ischaemic penumbra are discussed. While focusing on potentially new avenues of treatment, the issue of why many clinical stroke trials have so far proved disappointing is addressed. This article provides a framework that can be used to generate testable hypotheses and treatment strategies that are linked to the appearance of specific pathophysiological events within the ischaemic brain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10441299     DOI: 10.1016/s0166-2236(99)01401-0

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  1105 in total

1.  The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function.

Authors:  W Fu; M Killen; C Culmsee; S Dhar; T K Pandita; M P Mattson
Journal:  J Mol Neurosci       Date:  2000 Feb-Apr       Impact factor: 3.444

Review 2.  Does apoptosis have a role in neurodegeneration?

Authors:  R M Gibson
Journal:  BMJ       Date:  2001-06-23

3.  Brain tissue responses to ischemia.

Authors:  J M Lee; M C Grabb; G J Zipfel; D W Choi
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

4.  Effect of Silk Fibroin on Neuroregeneration After Traumatic Brain Injury.

Authors:  M M Moisenovich; E Y Plotnikov; A M Moysenovich; D N Silachev; T I Danilina; E S Savchenko; M M Bobrova; L A Safonova; V V Tatarskiy; M S Kotliarova; I I Agapov; D B Zorov
Journal:  Neurochem Res       Date:  2018-12-05       Impact factor: 3.996

5.  Preconditioning with a novel metallopharmaceutical NO donor in anesthetized rats subjected to brain ischemia/reperfusion.

Authors:  Marcio Wilker Soares Campelo; Reinaldo Barreto Oriá; Luiz Gonzaga de França Lopes; Gerly Anne de Castro Brito; Armenio Aguiar dos Santos; Raquel Cavalcante de Vasconcelos; Francisco Ordelei Nascimento da Silva; Beatrice Nuto Nobrega; Moisés Tolentino Bento-Silva; Paulo Roberto Leitão de Vasconcelos
Journal:  Neurochem Res       Date:  2011-12-10       Impact factor: 3.996

6.  First-order mathematical modeling of brain swelling in focal cerebral ischemia.

Authors:  Guang Jin; Phillip Zhe Sun; Aneesh B Singhal; Cenk Ayata; Eng H Lo
Journal:  Transl Stroke Res       Date:  2010-01-20       Impact factor: 6.829

Review 7.  Stress as necessary component of realistic recovery in animal models of experimental stroke.

Authors:  Frederick R Walker; Kimberley A Jones; Madeleine J Patience; Zidan Zhao; Michael Nilsson
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-11       Impact factor: 6.200

8.  Implications of immune system in stroke for novel therapeutic approaches.

Authors:  Aaron A Hall; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2010-01-13       Impact factor: 6.829

Review 9.  Does Na⁺/Ca²⁺ exchanger, NCX, represent a new druggable target in stroke intervention?

Authors:  Giuseppe Pignataro; Rossana Sirabella; Serenella Anzilotti; Gianfranco Di Renzo; Lucio Annunziato
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

10.  Leukocytosis in patients with neurologic deterioration after acute ischemic stroke is associated with poor outcomes.

Authors:  Andre D Kumar; Amelia K Boehme; James E Siegler; Michael Gillette; Karen C Albright; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-09-30       Impact factor: 2.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.